The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro
- PMID: 2013111
- DOI: 10.1007/BF00685154
The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro
Abstract
The effect of tumor cell density on the cellular pharmacokinetics of doxorubicin (DXR) and cisplatin (CDDP) was studied using MOLT-3 human acute lymphoblastic leukemia cells. As determined by the MTT assay, the growth-inhibitory effect of DXR was approx. 40 times lower when cell density was increased from 10(6) to 10(8) cells/ml (positive inoculum effect), whereas little or no influence of cell density was observed in CDDP-induced cell-growth inhibition. As measured by high-performance liquid chromatography using a fluorescence detector, the cellular accumulation of DXR showed 6- and 18-fold decreases after 1 h incubation when the cells were concentrated from 10(6) to 10(7) and 10(8) cells/ml, respectively. Only at low cell density (10(6) cells/ml) did the amount of DXR in the cells increase with increasing exposure times of up to 6 h. The DXR concentration in the supernatant that was separated from a cell suspension showing a density of 10(8) cells/ml fell to 20% of that obtained at 10(6) cells/ml. The metabolites of DXR, including Adriamycinol and Adriamycinone, were not detectable in the cell extracts or supernatants at any cell density examined. In contrast, the cellular accumulation of CDDP calculated from the platinum concentration, which was measured with a flameless atomic absorption spectrophotometer, was essentially identical at all cell densities examined; moreover, extension of the exposure period resulted in a linear increase in the amount of CDDP in the cells. CDDP concentrations in the supernatants were equally retained, irrespective of cell densities. These observations indicate that the positive inoculum effect shown in DXR-induced cell-growth inhibition results from the decreased cellular accumulation of the drug at high cell densities. We found no influence for cell density on the cellular accumulation of CDDP that might be relevant to the therapeutic potentiation of this drug at high tumor-cell density.
Similar articles
-
Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine: mechanism of inoculum effects.Cancer Chemother Pharmacol. 1992;31(1):6-10. doi: 10.1007/BF00695987. Cancer Chemother Pharmacol. 1992. PMID: 1458560
-
Antitumor efficacy of doxorubicin in combination with cisplatin on human lymphoma cells at various cell densities in vitro.Keio J Med. 1991 Jun;40(2):78-81. doi: 10.2302/kjm.40.78. Keio J Med. 1991. PMID: 1881027
-
Effects of doxorubicin and cisplatin on multicellular tumor spheroids from human lung cancer.Cancer Drug Deliv. 1987;4(4):213-24. doi: 10.1089/cdd.1987.4.213. Cancer Drug Deliv. 1987. PMID: 3454248
-
Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes.Biochim Biophys Acta. 1988 May 12;965(2-3):136-45. doi: 10.1016/0304-4165(88)90049-9. Biochim Biophys Acta. 1988. PMID: 3365449
-
The synergistic and antagonistic effects of cytotoxic and biological agents on the in vitro antitumour effects of suramin.Eur J Cancer. 1994;30A(10):1545-9. doi: 10.1016/0959-8049(94)00285-d. Eur J Cancer. 1994. PMID: 7833116
Cited by
-
Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.J Clin Invest. 1995 Aug;96(2):1026-34. doi: 10.1172/JCI118088. J Clin Invest. 1995. PMID: 7543490 Free PMC article.
-
Cellular pharmacokinetics of ZD1694 in cultured human leukaemia cells sensitive, or made resistant, to this drug.J Cancer Res Clin Oncol. 1996;122(2):109-17. doi: 10.1007/BF01226268. J Cancer Res Clin Oncol. 1996. PMID: 8576277 Free PMC article.
-
In Vitro Research Reproducibility: Keeping Up High Standards.Front Pharmacol. 2019 Dec 10;10:1484. doi: 10.3389/fphar.2019.01484. eCollection 2019. Front Pharmacol. 2019. PMID: 31920667 Free PMC article.
-
The Chemistry and Biology of Nakiterpiosin - C-nor-D-Homosteroids.Synlett. 2012 Oct;16(23):2298-2310. doi: 10.1055/s-0031-1290460. Synlett. 2012. PMID: 23226922 Free PMC article.
-
Antitumor activities of new platinum compounds, DWA2114R, NK121 and 254-S, against human leukemia cells sensitive or resistant to cisplatin.Invest New Drugs. 1991 Nov;9(4):313-9. doi: 10.1007/BF00183571. Invest New Drugs. 1991. PMID: 1804804
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials